We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » High Court Denies Merck’s Appeal on Cubicin Patents
High Court Denies Merck’s Appeal on Cubicin Patents
A Merck unit will lose four of its five patents on its skin infection therapy Cubicin after the U.S. Supreme Court denied the drugmaker’s appeal Tuesday.